Human IL-2 Receptor alpha ELISA Kit
CAT.NO. : AEH0170
US$ Please choose
US$ Please choose
Size:
Trail, Bulk size or Custom requests Please contact us
Background
Two type1 membrane proteins belonging to the hemopoietin receptor family have been cloned and shown to bind IL-13 with differing affinities. The lower affinity IL-13 binding protein, previously designated IL-13 R alpha, IL-13 R alpha l or NR4, is now referred to as IL-13 R alpha 1. The high affinity IL-13 binding protein, previously also designated IL-13 R or IL-13 R alpha l, is now referred to as IL-13 R alpha 2. Human IL-13 R alpha 2 was originally cloned from the Caki-1 human renal carcinoma cell line. The IL-13 R alpha 2 cDNA encodes a 380 amino acid (aa) residue precursor protein with a putative 26 aa residue signal peptide, a 317 residue extracellular domain, a 20 aa residue transmembrane region and a 17 aa residue cytoplasmic tail. Human and mouse IL‑13 R alpha 2 share 59% aa sequence identity. The extracellular domain of IL-13 R alpha 2 is also closely related to that of IL-13 R alpha 1. However, the 17 aa residue cytoplasmic domain of IL-13 R alpha 2 is much shorter than that of IL-13 R alpha 1, suggesting that the two receptors are functionally distinct. IL-13 R alpha 1 has been shown to combine with the IL-4 R to form a high-affinity receptor complex capable of transducing an IL‑13‑dependent proliferative signal. The role of IL-13 R alpha 2 in IL-13 signaling remains to be elucidated. The amino-terminal 27 aa residues of the human and mouse IL‑13 R alpha 2 are nearly identical to that of a soluble mouse IL-13 binding protein purified from mouse serum and urine.
Typical data
|
pg/ml |
O.D. |
Average |
Corrected |
|
|
0.00 |
0.0082 |
0.0086 |
0.0084 |
|
|
1.37 |
0.0274 |
0.0256 |
0.0265 |
0.0181 |
|
4.12 |
0.0649 |
0.0683 |
0.0666 |
0.0582 |
|
12.35 |
0.1922 |
0.1804 |
0.1863 |
0.1779 |
|
37.04 |
0.4898 |
0.4806 |
0.4852 |
0.4768 |
|
111.11 |
1.2600 |
1.1500 |
1.2050 |
1.1966 |
|
333.33 |
2.4250 |
2.4020 |
2.4135 |
2.4051 |
|
1000.00 |
3.6340 |
3.6390 |
3.6365 |
3.6281 |
Precision
|
Intra-assay Precision |
Inter-assay Precision |
|||||
|
Sample Number |
S1 |
S2 |
S3 |
S1 |
S2 |
S3 |
|
22 |
22 |
22 |
6 |
6 |
6 |
|
|
Average(pg/ml) |
19.2 |
115.7 |
350.8 |
18.1 |
103.6 |
361.9 |
|
Standard Deviation |
0.9 |
5.4 |
18.3 |
0.7 |
4.9 |
14.8 |
|
Coefficient of Variation(%) |
4.7 |
4.7 |
5.2 |
3.9 |
4.7 |
4.1 |
Spike Recovery
The spike recovery was evaluated by spiking 3 levels of human IL-2 Receptor alpha into health human serum sample. The un-spiked serum was used as blank in this experiment.
The recovery ranged from 89% to 118% with an overall mean recovery of 106%.
The recovery ranged from 89% to 118% with an overall mean recovery of 106%.
Sample Values
| Sample Matrix | Sample Evaluated | Range (pg/ml) | Detectable (%) | Mean of Detectable (pg/ml) |
|---|---|---|---|---|
| Serum | 30 | 722.90-1772.29 | 100 | 1340.94 |
New Products
